InvestorsObserver
×
News Home

What is the Market's View on Gossamer Bio Inc (GOSS) Stock's Price and Volume Trends Friday?

Friday, September 02, 2022 01:05 PM | InvestorsObserver Analysts

Mentioned in this article

What is the Market's View on Gossamer Bio Inc (GOSS) Stock's Price and Volume Trends Friday?

Overall market sentiment has been high on Gossamer Bio Inc (GOSS) stock lately. GOSS receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bullish
Gossamer Bio Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on GOSS!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With GOSS Stock Today?

Gossamer Bio Inc (GOSS) stock is trading at $14.40 as of 1:04 PM on Friday, Sep 2, a decline of -$0.18, or -1.23% from the previous closing price of $14.58. The stock has traded between $13.82 and $14.87 so far today. Volume today is light. So far 257,745 shares have traded compared to average volume of 1,023,764 shares. To see InvestorsObserver's Sentiment Score for Gossamer Bio Inc click here.

More About Gossamer Bio Inc

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Click Here to get the full Stock Report for Gossamer Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App